Japan Commits to Comparability Protocols as ICH Q12 Takes Shape
This article was originally published in The Gold Sheet
Executive Summary
Japan’s decision to adopt comparability protocols will help smooth the way for the global post-approval changes that Q12 will enable.
You may also be interested in...
Global Post-Approval Changes Outlook Murky As Q12 Lurches Into Consultation
ICH finally proposes a way to resolve the regulatory complexity that has prevented drug makers from establishing and perfecting global approaches to manufacturing their drug products. But with legal concerns persisting in Europe and possibly lurking elsewhere, approval of ICH's draft Q12 guideline could be difficult.
ICH Seeks To Resolve Impasse Over Q12 Legal Review This Week
It remains uncertain whether a legal review by the European Commission that since June has delayed public consultation of draft ICH Q12 post-approval changes guideline can be resolved during this week's ICH meeting in Geneva.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.